Bipartisan Decision Instructs US To Affect Hashish De-Scheduling From UN Treaty

By Nicolas Jose Rodriguez

Representatives Nancy Mace (R) and Barbara Lee (D) filed a resolution on Friday expressing “the sense of Congress” that the United States representative to the United Nations Commission on Narcotic Drugs should use “the voice, vote, and influence of the United States to seek to de-schedule cannabis from Schedule I of the Single Convention on Narcotic Drugs of 1961 and treat the plant “as a commodity.”

In 2020, the UN’s Commission for Narcotic Drugs voted to remove medicinal cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs, following recommendations from the World Health Organization.

Photo by VICTOR DE SCHWANBERG/Getty Images

The US voted in favor of removing cannabis from Schedule IV, however, cannabis and cannabis resin are still on Schedule I.

RELATED: The Downside Of Declassifying Cannabis As A Schedule 1 Drug

“Many countries would deschedule cannabis and reevaluate how cannabis is classified if the UN did so. Cannabis has been shown to be effective in the treatment of numerous medical conditions such as epilepsy, PTSD, cancer pain relief, nausea, and chronic and terminal illnesses. Descheduling at the UN would support global research into how cannabis can treat a wide range of ailments and conditions,” stated Rep. Mace in a press release on Friday.

RELATED: 5 NATO Countries That Support Cannabis Legalization

United Nations Commission Reschedules Cannabis In Historic Vote Following WHO SuggestionPhoto by Oliver Helbig/Getty Images

“Scientific research has shown that cannabis has wide-ranging positive effects on chronic illness treatment. The classification of cannabis as a schedule one drug is outdated, out of touch, and should be addressed not only in the United States but around the world. The United States should be leading the way on cannabis reform on the global stage, and descheduling at the United Nations would be a great start,” added Rep. Lee.

This article originally appeared on Benzinga and has been reposted with permission.

Comments are closed.